Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Abbott Laboratories (ABT) COM STK NPV

Sell:$82.64 Buy:$82.65 Change: $0.87 (1.06%)
Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:$82.64
Buy:$82.65
Change: $0.87 (1.06%)
Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:$82.64
Buy:$82.65
Change: $0.87 (1.06%)
Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.

Contact details

Address:
100 Abbott Park Rd
ABBOTT PARK
60064-3500
United States
Telephone:
+1 (224) 6676100
Website:
www.abbott.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ABT
ISIN:
US0028241000
Market cap:
$144.89 billion
Shares in issue:
1.77 billion
Sector:
Health Care Equipment
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Miles White
    Chairman of the Board, Chief Executive Officer
  • Robert Ford
    President, Chief Operating Officer
  • Brian Yoor
    Chief Financial Officer, Executive Vice President - Finance
  • Hubert Allen
    Executive Vice President, General Counsel, Secretary
  • Jaime Contreras
    Senior Vice President - Core Laboratory Diagnostics, Commercial Operations
  • Daniel Salvadori
    Senior Vice President - Established Pharmaceuticals, Latin America.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.